BioSpace News Archive

Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics

Health Catalyst Data Operating System supplies insights that will improve award-winning health system’s revenue cycle management, drive operational excellence

-Interim data expected in 1H 2019-

Vik Shah Named COO; Elena Izmailova, Ph.D. Named Chief Scientific Officer; Gol Ophir Named Head of Business Development

Study Demonstrates Utility of Assay in Neoadjuvant and Adjuvant Treatment Settings

Brii Biosciences, a company committed to serving patients’ needs and improving public health in China, today announced several research collaborations that significantly advance its efforts to develop innovative medicines to meet the unique needs of patients in China.

Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research and production, today announced that it partnered with researchers at the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney to complete a study examining the effects of cannabis on driving and cognitive function.

The FDA is committed to doing what is can to stimulate the development of more products by improving the consistency and efficiency fueling biotech and pharma companies in the pharmaceutical industry forge ahead seeking positive results of clinical trials towards new treatments for various rare diseases, including numerous forms of cancer.

US Patent 10,136,929 entitled “Flexible Bone Implant” is the first patent to issue from the intellectual property portfolio held by the company that includes additional pending US and international patent applications.

To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024